The cyclooxygenase-2 inhibitors are not antiplatelet drugs. [2] In 1998 only one drug in this class was available, a monoclonal antibody (abciximab) directed against the fibrinogen receptor on the ...
Tribune Content Agency on MSN2d
The Medicine Cabinet: Ask the Harvard Experts: The better names for blood thinnersQ: I was recently asked if I take a blood thinner. I wasn’t sure how to answer the question because I occasionally take ...
Sportschosun on MSN13h
Presenting the appropriate duration of medication after carotid stenting...Less than half a year is enough to reduce the risk of bleedingA is a graph comparing the occurrence of ischemic stroke and major bleeding (cerebral hemorrhage, intestinal hemorrhage ...
The antiplatelet drug has been recommended for approval by the US regulator's cardiovascular and renal drugs advisory committee, which voted 10-1 in favour. The anticlotting agent would be the ...
A study from the Karolinska Institutet in Sweden has found that some commonly used cardiovascular medications are linked to a ...
Expert Rev Cardiovasc Ther. 2007;5(5):939-953. Although conflicting, these emerging clinical data have raised legitimate concerns and led to a special US FDA meeting in December 2006 to review the ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Guidelines continue to recommend standard dual antiplatelet therapy while endorsing de-escalating therapy and ...
Despite the widespread availability of antiplatelet drugs, heart attacks caused by platelet-triggered coronary vessel clots persist in many patients taking these medications. Lifestyle choices to ...
Since the advent of drug-eluting stents, there has been a debate in the intervention community over how long dual antiplatelet therapy should last after PCI. Cardiologists have to carefully ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback